Ruiling Feng

628 total citations
31 papers, 220 citations indexed

About

Ruiling Feng is a scholar working on Physiology, Immunology and Surgery. According to data from OpenAlex, Ruiling Feng has authored 31 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Immunology and 7 papers in Surgery. Recurrent topics in Ruiling Feng's work include Salivary Gland Disorders and Functions (11 papers), Systemic Lupus Erythematosus Research (7 papers) and Diabetes and associated disorders (4 papers). Ruiling Feng is often cited by papers focused on Salivary Gland Disorders and Functions (11 papers), Systemic Lupus Erythematosus Research (7 papers) and Diabetes and associated disorders (4 papers). Ruiling Feng collaborates with scholars based in China, United States and Hong Kong. Ruiling Feng's co-authors include Jing He, Xiaolin Sun, Zhanguo Li, Yoshimori An, Miao Miao, Weiqun Ao, Zhihua Xu, Yuqing Gao, Jiali Chen and Xia Zhang and has published in prestigious journals such as Frontiers in Immunology, Oncotarget and Frontiers in Pharmacology.

In The Last Decade

Ruiling Feng

26 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruiling Feng China 9 63 57 46 44 40 31 220
Laura De Michieli Italy 10 73 1.2× 24 0.4× 22 0.5× 41 0.9× 30 0.8× 42 322
P. M. Kern Germany 8 98 1.6× 108 1.9× 35 0.8× 29 0.7× 27 0.7× 10 275
Michael Gernert Germany 10 17 0.3× 104 1.8× 29 0.6× 42 1.0× 79 2.0× 34 295
Matteo Casale Italy 9 26 0.4× 49 0.9× 15 0.3× 16 0.4× 30 0.8× 28 262
Ioanna Tatouli Greece 4 20 0.3× 67 1.2× 123 2.7× 17 0.4× 106 2.6× 5 251
Émilie Chalayer France 11 11 0.2× 39 0.7× 33 0.7× 20 0.5× 61 1.5× 32 245
Slavica Marković Serbia 8 105 1.7× 33 0.6× 14 0.3× 22 0.5× 11 0.3× 26 282
A. Laíz Spain 10 11 0.2× 84 1.5× 40 0.9× 21 0.5× 128 3.2× 45 272
Panagiotis Antiochos Switzerland 10 59 0.9× 55 1.0× 17 0.4× 11 0.3× 26 0.7× 60 284
Nouran Abaza Egypt 11 18 0.3× 66 1.2× 11 0.2× 20 0.5× 130 3.3× 22 227

Countries citing papers authored by Ruiling Feng

Since Specialization
Citations

This map shows the geographic impact of Ruiling Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiling Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiling Feng more than expected).

Fields of papers citing papers by Ruiling Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiling Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiling Feng. The network helps show where Ruiling Feng may publish in the future.

Co-authorship network of co-authors of Ruiling Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiling Feng. A scholar is included among the top collaborators of Ruiling Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiling Feng. Ruiling Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qinghong, Yuqing Zeng, Ruiling Feng, et al.. (2025). Evaluating the therapeutic potential of tofacitinib in Sjögren’s disease: a comprehensive clinical and immunological assessment. Lara D. Veeken. 64(11). 5899–5910. 2 indexed citations
2.
Zhang, Kai, Peng Zhao, Bo Huang, et al.. (2025). Clinical characteristics and treatment response of patients with SLE complicated with thrombotic thrombocytopenic purpura. Lupus Science & Medicine. 12(2). e001740–e001740.
3.
Han, Yipeng, Ruoyi Wang, Ruiling Feng, et al.. (2025). Anti-SSA/SSB antibody double-negative Sjögren’s disease patients: a comprehensive clinical study and immune profile. Clinical Rheumatology. 44(4). 1625–1633. 2 indexed citations
4.
Zhang, Zhening, Tong Xie, Yudong Liu, et al.. (2025). Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer. Frontiers in Immunology. 16. 1559275–1559275.
5.
Qi, Xuan, Doudou Zhao, Yipeng Han, et al.. (2025). B lymphocyte subset-based stratification in primary Sjögren’s syndrome: implications for lymphoma risk and personalized treatment. Clinical Rheumatology. 44(6). 2403–2412.
6.
Wu, Jingchun, et al.. (2025). Impact of disease duration on systemic clinical profile in Sjogren’s syndrome. Arthritis Research & Therapy. 27(1). 39–39. 1 indexed citations
7.
Yan, Hui, et al.. (2024). Distribution of blood lead and cadmium levels in healthy children aged 0 to 18 years and analysis of related influencing factors in Henan, China: data findings from 2017 to 2022. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 50(1). 43–43. 2 indexed citations
8.
Feng, Ruiling, Xian Xiao, Bo Huang, et al.. (2024). Metabolic impact of low dose IL-2 therapy for primary Sjögren’s Syndrome in a double-blind, randomized clinical trial. Clinical Rheumatology. 43(12). 3789–3798. 2 indexed citations
9.
Feng, Ruiling, Xian Xiao, Bo Huang, et al.. (2024). Predictive biomarkers for low-dose IL-2 therapy efficacy in systemic lupus erythematosus: a clinical analysis. Arthritis Research & Therapy. 26(1). 180–180. 2 indexed citations
10.
Feng, Ruiling, et al.. (2023). Prognostic model of ER-positive, HER2-negative breast cancer predicted by clinically relevant indicators. Clinical & Translational Oncology. 26(2). 389–397. 1 indexed citations
11.
Feng, Ruiling, Gong Cheng, Bo Huang, et al.. (2022). Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model. Frontiers in Medicine. 9. 887354–887354. 5 indexed citations
12.
Zhai, Bo, Ruiling Feng, Yaodong Zhang, et al.. (2022). Prevalence of Congenital Heart Disease in Chinese Children With Different Birth Weights and Its Relationship to the Neonatal Birth Weight. Frontiers in Pediatrics. 10. 828300–828300. 2 indexed citations
13.
Zhang, Xia, et al.. (2021). Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis. Rheumatology and Therapy. 8(4). 1905–1914. 8 indexed citations
14.
Zhang, Xia, et al.. (2021). Sonoelastography of salivary glands for diagnosis and clinical evaluation in primary Sjögren's syndrome. Clinical and Experimental Rheumatology. 39(6). 184–189. 8 indexed citations
15.
Zhou, Yang, Qiang Zhou, Ruiling Feng, et al.. (2021). Beta-Lapachone Attenuates BMSC-Mediated Neuroblastoma Malignant Transformation by Inhibiting Gal-3/Gal-3BP/IL6 Axis. Frontiers in Pharmacology. 12. 766909–766909. 7 indexed citations
16.
Miao, Miao, Xian Xiao, Ruiling Feng, et al.. (2021). Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study. Arthritis Research & Therapy. 23(1). 167–167. 32 indexed citations
17.
Xu, Ying, et al.. (2018). Analysis of Related Factors for the Retention Time of Tracheobronchial Foreign Bodies in Pediatrics. Journal of Surgical Research. 233. 262–267. 5 indexed citations
18.
Xu, Ying, et al.. (2018). Correlative factors for the location of tracheobronchial foreign bodies in infants and children. Journal of Thoracic Disease. 10(2). 1037–1042. 11 indexed citations
19.
Lin, Yubi, Zili Liao, Ruiling Feng, et al.. (2017). Whole exome sequencing identified a pathogenic mutation in RYR2 in a Chinese family with unexplained sudden death. Journal of Electrocardiology. 51(2). 309–315. 8 indexed citations
20.
Lin, Yubi, Ruiling Feng, Zhe Xu, et al.. (2017). Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network. Oncotarget. 8(34). 57003–57011. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura De Michieli Breakdown of academic impact, for papers by P. M. Kern Breakdown of academic impact, for papers by Michael Gernert Breakdown of academic impact, for papers by Matteo Casale Breakdown of academic impact, for papers by Ioanna Tatouli Breakdown of academic impact, for papers by Émilie Chalayer Breakdown of academic impact, for papers by Slavica Marković Breakdown of academic impact, for papers by A. Laíz Breakdown of academic impact, for papers by Panagiotis Antiochos Breakdown of academic impact, for papers by Nouran Abaza
Rankless by CCL
2026